Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This was a randomized, double-blind, active-controlled, parallel-group, multicenter study in adult hospitalized patients to establish the safety and efficacy of ceftobiprole medocaril compared with vancomycin plus aztreonam in the treatment of acute bacterial skin and skin structure infections (ABSSSIs).
Epistemonikos ID: 54d23fe9c3d4700a804878a482b4fbd551e86c28
First added on: May 20, 2024